4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-19-000114
Options or other derivatives
- CHIEF BUSINESS OFFICER acquired 80,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/form4-01312019_040109.xml…